Postmarket Surveillance of Medical Devices: A Comparison of Strategies in the US, EU, Japan, and China | PLOS Medicine
July 2011 digital edition of Pharmacy Practice News by McMahon Group - Issuu
Guidance for Industry
Processes | Free Full-Text | The Effect of Medical Device Regulations on Deploying a Lean Six Sigma Project
The Food and Drug Administration's (FDA's) 510(k) Process: A Systematic Review of 1000 Cases - The American Journal of Medicine
New Medical Device and Therapeutic Approvals in Otolaryngology: State of the Art Review of 2021 - Alexander M. Choi, Michael J. Brenner, Daniel Gorelik, Isaac D. Erbele, Matthew G. Crowson, Prajoy Kadkade,
Diabetes Tests, Programs and Supplies 1 of 44 07/06/2015 11:29 AM
In vitro stability of biosimilar insulin aspart SAR341402 in the Medtronic MiniMed insulin pumps - Journal of Pharmaceutical Sciences
GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System | Gore Medical
SUMMARY OF SAFETY AND EFFECTIVENESS DATA (SSED)
Hearing Aids and Devices Including Wearable, Bone Anchored and Semi-Implantable – Individual Exchange Medical Policy
Bioengineering | Free Full-Text | Impact of an Accessory for Left Ventricular Assist Devices on Device Flow and Pressure Head In Vitro
How FDA Regulates Artificial Intelligence in Medical Products | The Pew Charitable Trusts
1.01.30 Artificial Pancreas Device Systems
Long-Term Clinical Effectiveness of a Drug-Coated Balloon for the Treatment of Femoropopliteal Lesions | Circulation: Cardiovascular Interventions
American Association of Clinical Endocrinology Clinical Practice Guideline: The Use of Advanced Technology in the Management of Persons With Diabetes Mellitus - Endocrine Practice
FDA Regulation of Medical Devices - EveryCRSReport.com
Management of diabetes and hyperglycaemia in the hospital - The Lancet Diabetes & Endocrinology
Study Design and Data Analysis of Artificial Pancreas Device Systems with Closed-Loop Glucose-Sensing Insulin Delivery
Clinical Evidence Supporting FDA Clearance of First-of-a-Kind Therapeutic Devices via the De Novo Pathway Between 2011 and 2019 | medRxiv
